Trial NCT03051672

View at ClinicalTrials.gov 
Org. Study IDs: 16-588

Last trial update was posted on 2021-04-27

MeSH Interventions

Pembrolizumab

MeSH Conditions

Breast Neoplasms

Other Conditions

Metastatic Breast Cancer

Stopping Reasons

Based on two-stage design, the study ended at stage 1 with no evidence of promise based on pre-specified decision rule.

Limitations And Caveats

N/A

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID